Li AM, Hucks GE, Dinofia AM, et al. Checkpoint inhibitors augment CD19-directed chimeric antigen receptor (CAR) T cell therapy in relapsed B-cell acute lymphoblastic leukemia. ASH Annual Meeting and Exposition 2018, abstract 556.
RUNX1-remmers verhinderen groei primaire T-ALL-cellen
okt 2017 | Leukemie